Event attendance:
In person
Date & time:
-
Location:
Housman Room, UCL
[Past] Transforming the success of keyhole surgery with AI-enhanced imaging
A Housman Talk by Dr Maria Leiloglou, CEO of Enacuity
This event is in the past. If you would like more information including on the technology and Enacuity, please contact events@uclventures.com
AI-powered surgical imaging is opening up new possibilities for safer, more effective minimally invasive surgery. Dr Maria Leiloglou, founder and CEO of Enacuity, will share the story behind the UCL and Imperial spinout’s journey from research insight to commercial venture.
The aim of the Housman talks is to promote collegiality, encourage interdisciplinary relations and introduce new ASCR members to other users of the Housman Room.
By invitation and only open to ASCR members.
Our team attending
Marina Santilli
Interim Director of Physical Sciences & Engineering
Marina has specialised in the commercialisation of computer science and AI-based inventions and deep tech venture building since joining UCL Ventures in 2007. She headed straight into industry after
graduating in Physics from Imperial College, enjoying a successful career in datacomms engineering and becoming Director of new product development at Verizon.
In 2010 she designed and developed E-lucid, a platform to enable online licensing of UCL’s intellectual property. E-lucid is now used by over 30 research institutions around the world and was spun out as a commercial business in 2023.
Marina was involved in the formation of many successful UCL spinouts including Satalia, Re:infer, 3DRepo, MatrixMill, Humanloop, Stanhope AI.
Dr Weng Sie Wong
Senior Business Manager
Dr Wong brings extensive experience of all aspects of university technology transfer activities from strategic IP management to licence negotiations and spinout formation.
As a Senior Business
Manager focusing on the commercialisation of medical technologies, healthcare engineering, medical imaging and AI-enabled healthcare innovations arising from UCL research, she has been involved in the formation of multiple spinouts and acted as a director on various boards.
Prior to joining UCL Ventures, Dr Wong was a senior technology transfer manager at Oxford University’s TTO, Oxford University Innovation, working on a diverse range of both life and physical science projects over a 10-year period.
Weng holds an MBA from Edinburgh University and a PhD in pharmacology from UCL.
Dr. Barny Cox
Senior Business Manager
Dr Cox is responsible for assisting in the commercial exploitation of IP arising from UCL’s departments of Medicine, Structural and Molecular Biology, Infection and Immunity, Chemical Biology,
Biochemical Engineering, Medical Physics and BioEngineering, Epidemeology and Health and Psychology and Language Sciences.
Prior to joining UCL Ventures, Barny was a technology transfer manager at Queen Mary Innovation, where in addition to acting as a director on the board and company secretariat to a Queen Mary, University of London spinout, he gained a wealth of experience in the commercialisation of a broad portfolio of healthcare and other life science-related technologies, assisting in the patent prosecution of new commercially-viable innovations, the acquisition of translational funds and successful marketing, negotiation and execution of a number of out-licensing deals.
Barny has previously held positions with the British Medical Association and two internationally-acclaimed patent and trademark firms, where he gained a thorough grounding in intellectual property prosecution.
He completed an MRC Career Development Fellowship at the National Institute for Medical Research in the field of developmental neurobiology, studying the morphogenic Sonic Hedgehog signalling cascade in mammalian neural tube cell-fate specification and holds a doctorate awarded by UCL.
Dr Adam Hajjar, Business Manager
Billy Lam, Business Manager